मुख्य मजकुरावर जा
शनि, २१, नोव्हें २०२६ · पुणे
Pharma Solutions Indiaबातम्या · नोकऱ्या · MSPC मदत · क्लासेस
बातम्यांकडे परत
pharma २२ ऑग 2 मिनिटांचं वाचन· New Delhi, India

PCI Invites Public Feedback on B.Pharm Syllabus Draft 2025

Big update for pharmacy students & educators!

लेखक Pharma Solutions India · २२ ऑगस्ट, २०२५

PCI Invites Public Feedback on B.Pharm Syllabus Draft 2025

एका नजरेत

संस्थाPharmacy Council
ठिकाणNew Delhi, India
विभागpharma
प्रकाशित२२ ऑगस्ट, २०२५
Public feedback invited to shape the future of B.Pharm education in India. Your voice matters!

मुख्य मुद्दे

  • Pharmacy Council of India (PCI) releases draft B.Pharm syllabus for public review.
  • Stakeholders, including students, academicians, and industry experts, encouraged to submit feedback.
  • Deadline for comments not specified—act fast to influence pharmacy education standards.
  • Proposed changes aim to align curriculum with global pharma industry demands and emerging technologies.

The Pharmacy Council of India (PCI) has taken a significant step toward modernizing pharmacy education by inviting public comments on its newly proposed B.Pharm syllabus draft. Released earlier this week, the draft aims to overhaul the existing curriculum to better align with global pharmaceutical trends, emerging technologies like AI in drug discovery, and industry demands for skilled professionals. Why does this matter? The B.Pharm syllabus hasn’t seen major revisions in years, and critics argue it lags behind international standards in areas like clinical pharmacy, biotechnology, and regulatory affairs. The PCI’s move signals a push toward a more competency based and industry relevant education system. Who can participate? The PCI has called for feedback from: - Students & alumni (your future depends on this!). - Academicians & professors (shape what you teach). - Pharma industry experts (ensure graduates are job ready). - Regulatory bodies & policymakers (align with national health goals). How to submit comments? Interested parties can review the draft syllabus on the [PCI’s official website]( of public comments on the proposed draft bpharm syllabus/) and submit their suggestions via the provided portal. While no official deadline has been announced, insiders suggest acting quickly to ensure your input is considered. Key areas under review include: - Expanded focus on clinical pharmacy & patient care (a long awaited shift). - Integration of digital health tools (AI, blockchain for supply chain). - Stronger emphasis on research & innovation (boosting India’s pharma R&D). - Updated regulatory affairs modules (keeping pace with global compliance). Controversies & concerns Some educators worry the new syllabus may overburden students with additional subjects, while industry leaders stress the need for practical training over theoretical load. *Will the PCI strike the right balance?* What’s next? After collecting feedback, the PCI will finalize the syllabus, which could roll out as early as 2026. This revision may also impact D.Pharm and M.Pharm programs in the future. Pro tip. If you’re a pharmacy student or professional, now is the time to speak up—your input could reshape how pharmacists are trained for decades!

pci.gov.in
The proposed syllabus is a step in the right direction, but it must include **mandatory industry internships** and **soft skills training** to produce well rounded pharmacists. The current draft still leans too heavily on theory.
Dr. Anil K. Sharma, Former Dean, Manipal College of Pharmaceutical Sciences

Official PCI Draft Syllabus Link

एका नजरेत

Contact PCI for queries[email protected]
Expected timelineFinal syllabus likely by Q1 2026

Related

हा सारांश फार्मा सोल्युशन्स इंडियाच्या टीमने तयार केला आहे. काही करण्यापूर्वी तारीख, फी आणि पात्रता संबंधित कार्यालयाकडे तपासून घ्या. संपादकीय धोरण · अस्वीकरण.

Advertisement